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Se debe estar en conocimiento de la geografía del destino
y los posibles riesgos de salud y la maneras de prevenirlos
doi:10.1016/j.ijid.2010.02.1478
02.003
Traveling with Kids
C. Perret
Pontiﬁcia Universidad Catolica de Chile, Santiago, Chile
Travelling with kids is a great adventure that offers
opportunities for fun and to possibility to broaden ones cul-
tural outlook. But travel is not just fun, some risks related
to the travel exist and the whole family should be prepared
to prevent them or to have early treatment. Preparing a trip
with kids involves considering several aspects, such as age,
underlying diseases and destination.
The main aspects we are going to review are: safety
travel (motor vehicles, safety water and food, air travel, sun
protection, motion sickness, high altitude, animal bites),
immunization, prevention of arthropods borne diseases and
diarrhea. Air transportation can produce boredom and ear
pain. No pharmaceutical interventions have been proved to
be good at preventing painful earache. Sedation is contro-
versial but if it is required, diphenhydramine is considered
a safe drug.
Children should have their immunization schedule
updated at the time of the trip. Insect borne disease can
be prevented by using DEET repellents. DEET concentration
30-35% is safe for use in children. It should not be applied
around the eyes, mouth or on the hands and forearms of
young children. Malaria chemoprophylaxis can be used in
children and are licensed for infants.
Meﬂoquine, chloroquine and malarone are the alterna-
tives for children under 9 years old.
Doxycicline can be used after that age. Maternal chemo-
prophylaxis is not enough for breastfed infants. Difﬁculties
for children using chemoprophylaxis include bad taste, luck
in pediatric preparations and toxicity risks. Diarrhea preven-
tion includes safety in water and food consumption. Therapy
should center on oral hydration. Self-treatment of trav-
elers’ diarrhea with antibiotics should be considered, but
antimotility agents should be avoided. Travel offers good
experiences for children and their families. Pre-travel eval-
uation and protective interventions can reduce the health
risks of travel.
doi:10.1016/j.ijid.2010.02.1479
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The Elderly Traveler
S. Lemos Hinrichsen
Universidade Federal de Peranbuco, and Universidade de
Pernambuco, Sao Paulo, Brazil
Old age has been divided into different groups: biolog-
ical, physiological, emotional and functional. Advances in
science and technology, as well as improvements in health
services available, have played an important role in the
increasing number of elderly in the world. The 20 th cen-
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ury saw an increase in both anticipated and actual life
xpectancy ﬁgures, a phenomenon described as the ‘aging
opulation’. In the year 2020, life expectancy at birth is pre-
icted to reach 70. Travel satisﬁes old age people needs for
dventure in many ways. Most personal problems stem from
ushing to meet a schedule of pleasure and joy. And during
ravels everything is permitted, specially food and sedentary
ctivities, most of them due to physical and health limits.
ut how far can they go traveling? If they have to share
heir travel with prescribed medicines; diabetes; neurolog-
cal problems; obesity and diets; vision and hearing loss;
alking limitations versus jet lag; altitudes problems; air-
ort/aircraft long stay/ pulmonary thromboembolism risks;
azy attitudes during cruises; infection disease risks and
dult immunization status.
oi:10.1016/j.ijid.2010.02.1480
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entral America and the Caribbean: Dengue and P.Vivax
alaria
. Torres
Tropical Medicine Institute, Caracas, Venezuela
In recent decades, the incidence, distribution and clini-
al severity of dengue have increased dramatically in most
ropical and subtropical areas worldwide. As a consequence,
nd due to the expanding international tourism, health
are providers in travel clinics of developed countries are
ncreasingly confronted with dengue, reﬂecting its global
mpact. No speciﬁc prophylactic or therapeutic agents exist
or dengue infections. All four serotypes of dengue viruses
re widespread in Central America and the Caribbean basin.
engue is most common in cities but can be found in rural
reas. It is rarely found in mountainous areas above 4,000
eet. Dengue fever is the most common cause of fever in
ravelers returning to the USA from the Caribbean and Cen-
ral America. In some case studies, dengue has been the
econd most common cause of hospitalization (malaria is
he most common) among travelers returning from the trop-
cs. Infection rates (based on anti-dengue serology) among
ebrile travelers returning from those areas may range from
.9% to 8.0%. Similar results have been reported in travel-
rs returning to Europe. Persons travelling to areas where
engue is endemic should avoid exposure to mosquitoes,
nd health care providers should consider dengue as a dif-
erential diagnosis in febrile travelers returning from the
ropics after discounting malaria. Surveillance of imported
engue is crucial to monitor the risk of infection for trav-
lers and to strengthen clinical awareness of the disease.
he risk for a traveler acquiring malaria differs substantially
rom different areas within the region and from traveler to
raveler, even within a single country. In a large series of
0,745 cases of malaria among U.S. residents reported to
DC from 1997 through 2006, 1,427 (13.3%) were acquired
n the Caribbean and Centra/South America. Malaria has
een reported in about 1 per 100,000 European travelers
o Central America and the Caribbean. The risk of vivax
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alaria may be relatively high in some Central American
ountries, including several large or middle size cities. Trav-
lers to malaria-risk areas, including infants, children, and
ormer residents of Mexico and Central America, should take
n antimalarial drug. There is no chloroquine resistance in
entral America, so this drug can still be recommended for
ravelers to these countries. Malaria is not a risk in most of
he Caribbean islands, but P. falciparum is endemic to most
f Haiti and some areas of the Dominican Republic, where
here is variable to low risk. Malaria in these areas is still
ensitive to chloroquine, which is therefore recommended
or prevention.
oi:10.1016/j.ijid.2010.02.1481
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antavirus and Bartonellosis
. Gotuzzo
Universidad Peruana Cayetano Heredia, Lima, Peru
No abstract received.
oi:10.1016/j.ijid.2010.02.1482
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ellow Fever transmission in Brazil
. Mascheretti
Centro de Vigilância Epidemiológica CVE/CCD/Secretaria
e Estado de Saúde de São Paulo, Sao Paulo, Brazil
Yellow fever (YF) is an arboviral disease caused by a
irus from Flaviviridae family and genus Flavivirus endemic
n tropical regions of Africa and South America. Transmis-
ion occurs after infected mosquito bite, genera Aedes
nd Haemogogus. Urban YF was eradicated in Brazil in
942, since than sporadic wild transmission has been main-
ained in country endemic area. From 1989 to 2008, 546
uman conﬁrmed cases YF were reported including 241
eaths (case fatality rate 44, 1%) in Brazil. During this
eriod north and midwestern region were responsible for
he highest number of cases registering human cases almost
very year. Beginning in 1999, YF virus underwent a geo-
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raphic expansion into southeast, south and midwestern
egion - Federal District, Goias, Sao Paulo, Minas Gerais,
arana and Rio Grande do Sul states — related to out-
reaks in areas that were silent for several decades and
utside Amazon area. This study describes the re-emergence
f YF virus in enzootic cycles involving mosquitoes, pri-
ates and humans cases in midwestern, southeast and
outh region during 2008 and 2009. During this period
nd explosive recording of monkey’s death was registry
y health authorities with laboratory conﬁrmed epizootics.
uman cases were associated with leisure and work activ-
ties in rural areas and occurred among unvaccinated
erson. Brazilian Ministry of Health considered it as a public
ealth event of national concern according to the Inter-
ational Health Regulations (2005). Epidemiological control
easures were adopted including entomologic control
nd assessments, monkey deaths surveillance investigation
nd mass vaccination campaigns were implemented. YF
accine-associated viscerotropic and neurotropic disease
ere reported. Those activities were important to estab-
ish an effective intervention to control and prevent future
utbreaks. Public health authority’s interest has been awak-
ned by reporting early identiﬁcation of YF virus circulation
o understand the potential geographic virus expansion and
eemergence.
oi:10.1016/j.ijid.2010.02.1483
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he Amazon II: Leishmaniasis and Chagas Diseases
. Sosa Estani
Institute for Clinical Effectiveness and Health Policy,
uenos Aires, Argentina
Chagas disease and leishmaniasis are the most impor-
ant vector-borne protozoan NTDs. Almost all of the 8-9
illion cases of Chagas disease (with approximately 50,000
ew cases annually) occur in poor rural and, increasingly,
any new urban and peri-urban areas of Latin America. Of
hese cases, an estimated 5.4 million people will develop
hronic Chagas heart disease, while 900,000 will develop
egaesophagus and megacolon. In LAC, the burden of dis-
ase caused by Trypanosoma cruzi infection is between ﬁve
o ten times greater than malaria. Chagas disease is dis-
roportionately represented among people living in poverty.
he disease has also emerged or re-emerged in areas of
onﬂict in Chiapas State, Mexico and Colombia. The major
pproaches to control including improved case manage-
